Bayer Wants More Fraud Claims Nixed In Trasylol MDL
Bayer AG has asked a judge to expand his dismissal of fraud claims in three suits to include others in the multidistrict litigation over the blood-clotting drug Trasylol, which Bayer pulled...To view the full article, register now.
Already a subscriber? Click here to view full article